Funding for this research was provided by:
L. K. Whittier Foundation
National Center for Advancing Translational Sciences (UL1TR001855 and UL1TR000130)
Received: 18 October 2017
Accepted: 11 October 2018
First Online: 24 October 2018
Ethics approval and consent to participate
: This study was granted ethics approval by the University of Southern California Health Science IRB (IRB# HS-17-00365) on 10/9/2017 and USC Institutional Biosafety Committee (BUA-17-00026). All participants provided written informed consent to participate. A copy of informed consent document has been included (Additional file InternalRef removed).
: Ian A Jones has nothing to disclose.Melissa Wilson has nothing to disclose.Ryan Togashi has nothing to disclose.Bo Han has nothing to disclose.Austin K. Mircheff, has nothing to disclose.C. Thomas Vangsness, Jr., is a shareholder and board member of CarthroniX.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.